Article Details
Retrieved on: 2020-12-14 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ublituximab, an investigational anti-CD20 antibody, outperformed Aubagio ... “B-cell targeted therapy with anti-CD20 <b>monoclonal antibodies</b> has ...
Article found on: multiplesclerosisnewstoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here